1.49 USD
▼-0.05-3.25%
盘后 1.84 0.00%
2026-09-16
市值
$13.25M
市盈率
—
EPS
-1.64
股息率
—
52 周区间
0.99 – 5.07
成交量
82.02K
Beta
0.94
目标价
4.00
52W 低 0.9952W 高 5.07
价格走势
公司简介
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as C...